Drugs / FTC
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01529749 Background | Feb → Mar 2012 | HIV infectious disease | Felipe Garcia | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FTC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01529749 ↗ |
| Route | Oral | “FTC/TDF --> 200/245 mg, oral” NCT01529749 ↗ |